[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Claire  Mazumdar Clemon M.B.A., Ph.D.", "age": 34, "title": "CEO & Director", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 829800, "exercisedValue": 0, "unexercisedValue": 5023506}, {"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 47, "title": "President, COO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 825750, "exercisedValue": 0, "unexercisedValue": 2526259}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 915375, "exercisedValue": 0, "unexercisedValue": 1986752}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 51, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Paul  Rodrique", "title": "Senior VP & Global Head of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.06, "open": 10.95, "dayLow": 10.33, "dayHigh": 10.95, "regularMarketPreviousClose": 11.06, "regularMarketOpen": 10.95, "regularMarketDayLow": 10.33, "regularMarketDayHigh": 10.95, "payoutRatio": 0.0, "forwardPE": -6.484472, "volume": 1041266, "regularMarketVolume": 1041266, "averageVolume": 414628, "averageVolume10days": 373700, "averageDailyVolume10Day": 373700, "bid": 7.71, "ask": 10.68, "bidSize": 2, "askSize": 18, "marketCap": 569636032, "fiftyTwoWeekLow": 7.8, "fiftyTwoWeekHigh": 28.09, "fiftyDayAverage": 11.3278, "twoHundredDayAverage": 12.7955, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 135268064, "profitMargins": 0.0, "floatShares": 24134236, "sharesOutstanding": 54562841, "sharesShort": 5392258, "sharesShortPriorMonth": 5588503, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0988, "heldPercentInsiders": 0.122329995, "heldPercentInstitutions": 0.93981004, "shortRatio": 18.0, "shortPercentOfFloat": 0.1546, "impliedSharesOutstanding": 54562841, "bookValue": 7.977, "priceToBook": 1.3087626, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -102672000, "trailingEps": -4.66, "forwardEps": -1.61, "enterpriseToEbitda": -1.118, "52WeekChange": -0.59106934, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 10.44, "targetHighPrice": 48.0, "targetLowPrice": 8.0, "targetMeanPrice": 31.42857, "targetMedianPrice": 36.0, "recommendationMean": 1.55556, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 436606016, "totalCashPerShare": 8.002, "ebitda": -121003000, "totalDebt": 2238000, "quickRatio": 25.344, "currentRatio": 25.796, "debtToEquity": 0.514, "returnOnAssets": -0.22848, "returnOnEquity": -0.32714, "freeCashflow": -68670376, "operatingCashflow": -100956000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Bicara Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1758315336, "regularMarketTime": 1758312003, "longName": "Bicara Therapeutics Inc.", "regularMarketChangePercent": -5.60579, "regularMarketPrice": 10.44, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "earningsTimestampEnd": 1762864200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.66, "epsForward": -1.61, "epsCurrentYear": -2.22125, "priceEpsCurrentYear": -4.700056, "fiftyDayAverageChange": -0.8878002, "fiftyDayAverageChangePercent": -0.07837358, "twoHundredDayAverageChange": -2.3555002, "twoHundredDayAverageChangePercent": -0.18408817, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": -0.862061, "postMarketPrice": 10.35, "postMarketChange": -0.0899992, "regularMarketChange": -0.620001, "regularMarketDayRange": "10.33 - 10.95", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 414628, "fiftyTwoWeekLowChange": 2.6399994, "fiftyTwoWeekLowChangePercent": 0.33846146, "fiftyTwoWeekRange": "7.8 - 28.09", "fiftyTwoWeekHighChange": -17.650002, "fiftyTwoWeekHighChangePercent": -0.62833756, "fiftyTwoWeekChangePercent": -59.106934, "earningsTimestamp": 1754971200, "earningsTimestampStart": 1762864200, "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]